New paradigms in cell death in human diabetic nephropathy
New paradigms in cell death in human diabetic nephropathy
7 de septiembre de 2010
Unbiased gene expression profiling identified novel cell death molecules in human diabetic nephropathy. The expression of TNFrelated apoptosis-inducing ligand (TRAIL), its decoy receptor osteoprotegerin, and receptors Fas (a Fas ligand receptor) and CD74 (a migration inhibitory factor (MIF) receptor) were induced in human diabetic nephropathy. Cell culture studies supported the functional relevance of this observation and the relationship to a high glucose environment. To define novel proapoptotic proteins upregulated in diabetic nephropathy, functional genomic screens for novel apoptosis mediators were integrated with genome-wide expression profiling and identified candidates for further functional analysis, including brain acid-soluble protein 1 (BASP1). Several lines of evidence point toward induction of endoplasmic reticulum stress response in human diabetic nephropathy. Functional studies defining an unequivocal contribution of endoplasmic reticulum stress to cell death in this setting are still needed. Further comparative studies will be required to define whether there is a specific aspect of apoptosis in progressive human diabetic nephropathy or whether the mechanisms are shared among all patients with chronic kidney disease. The next challenge will be to define the consequence of therapeutic interference of the apoptosis pathways in diabetic nephropathy and chronic kidney disease.
Available files
Current events
Current events
Stay informed with the latest news from our hospitals and health advancements, straight from our Current Events section.
- 6 de febrero de 2026
El Hospital de día Infanto Juvenil del Centre Mèdic l'Eixample Sagrat Cor, impulsa una charla motivacional...
El Hospital de Dia Infanto Juvenil del Centre Mèdic l'Eixample Sagrat Cor ha acogido recientemente una charla dirigida a adolescentes, impartida por Elías Vivancos, exbailar...Hospital Universitari Sagrat Coren/health-centers/hospital-universitari-sagrat-cor - 6 de febrero de 2026
Los betabloqueantes no aportan ningún beneficio tras un infarto de miocardio, ni en la fase aguda ni...
El Dr. Borja Ibáñez, director científico del CNIC, cardiólogo de la Fundación Jiménez Díaz, investigador de su Instituto de Investigación Sanitaria y jefe de grupo en el CIBE...Hospital Universitario Fundación Jiménez Díazen/health-centers/hospital-universitario-fundacion-jimenez-diaz - 5 de febrero de 2026
Lazos de apoyo contra el cáncer
El Hospital Quirónsalud Córdoba se adorna con globos y lazos verdes para promover la importancia de la prevención, la investigación y el acompañamiento a pacientes y familiasHospital Quirónsalud Córdobaen/health-centers/hospital-quironsalud-cordobaOncología Médicaen/specialities/oncologia-medica





